SCHEMBL5007260

SCHEMBL5007260

C=C(C)Cc1ccccc1[O]

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
ELANE P08246 1/20 0.36
AKR1B1 P15121 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34
ALOX15 P16050 1/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34
GFER P55789 1/20 0.34
KDM4E B2RXH2 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRB2 P47870 1/20 0.33
EGFR P00533 2/20 0.32
ATM Q13315 1/20 0.32
TSHR P16473 1/20 0.31
PKM P14618 1/20 0.31
APOBEC3G Q9HC16 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6015464 0.84 MEN1 (0.40) ALDH1A1ELANEAKR1B1MEN1KMT2A
SCHEMBL10612476 0.80 AKR1B1 (0.40) ALDH1A1AKR1B1KMT2AGAAMAPT
SCHEMBL714334 0.80 L3MBTL1 (0.50) ALDH1A1AKR1B1GAAMAPTL3MBTL1
SCHEMBL13689952 0.78 PKM (0.53) PKMMAOAMAOBCTBP2
SCHEMBL1930611 0.77 IFNAR1 (0.42) ALDH1A1MAPTAPOBEC3G
SCHEMBL13689908 0.77 AKR1B1 (0.57) ELANEAKR1B1MAPTKDM4EL3MBTL1
SCHEMBL18543737 0.76 CTBP2 (0.47) ALDH1A1MEN1KMT2AMAPTCASP7
SCHEMBL251843 0.76 AKR1B1 (0.56) AKR1B1MAPTKDM4ETSHRHSD17B10
SCHEMBL16371621 0.76 MAPT (0.35) ALDH1A1ELANEAKR1B1MEN1KMT2A
SCHEMBL10727693 0.75 GABRA1 (0.43) MEN1KMT2AGAAMAPTALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7414063-B2 Inhibitors of Akt (protein kinase B) ELI LILLY AND COMPANY (US) 2008-08-19 US disclosed
US-20070043040-A1 Inhibitors of akt (protein kinase b) ELI LILLY AND COMPANY 2007-02-22 US disclosed
US-4122062-A FILLERS KENRICH PETROCHEMICALS, INC. (US) 1978-10-24 US disclosed
US-4096110-A Filled polyesters containing organic titanate esters KENRICH PETROCHEMICALS, INC. (US) 1978-06-20 US disclosed
US-4087402-A USED FOR TREATMENT OF INORGANIC FILLERS KENRICH PETROCHEMICALS, INC. (US) 1978-05-02 US disclosed
US-4069192-A ORGANIC KENRICH PETROCHEMICALS, INC. (US) 1978-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043040-A1 Inhibitors of akt (protein kinase b) AKT1, AKT2, BRAF ALDH1A1 4411/4885ELANE 3436/4885AKR1B1 2518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.